Form 4 for ASND Ascendis Pharma A/S
Accepted 2026-06-01 16:11:13 ET · period of report 2026-05-29 · accession 0001610717-26-000177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-01 16:11 | 2026-05-29 | ASND | BIENAIME JEAN JACQUES | Dir | P - Purchase | $223.12 | +500 | 900 | +125% | +$111.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-29 | P | A | 200 | $223.76 | 600 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-05-29 | P | A | 200 | $222.30 | 800 | D | — | — | |
| 3 | Common | Ordinary Shares | 2026-05-29 | P | A | 100 | $223.50 | 900 | D | — | — |